To model the cooperation between loss of function of TET2 and the KIT D816V mutation in vitro, we knocked down (KD) TET2 in a human mast cell leukemia cell line (HMC-1.2) harboring the KIT D816V mutation. This evidence concerns the gene KIT and mast cell leukemia.